The BB1 Monoclonal Antibody Recognizes Both Cell Surface CD74 (MHC Class II-Associated Invariant Chain) as Well as B7-1 (CD80), Resolving the Question Regarding a Third CD28/CTLA-4 Counterreceptor
Gordon J. Freeman(Dana-Farber Cancer Institute), Lee M. Nadler(Dana-Farber Cancer Institute), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Angelo A. Cardoso(Centro Infantil Boldrini), Richard Groves(St John's Hospital), Anukanth Anumanthan(Boston University), Thomas S. Kupper(Brigham and Women's Hospital), Edward A. Clark(St Vincent Hospital)
Cited by 45
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k